Please assess the completion status of the following clinical trial:

Trial Title: Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:The patient~* has a diagnosis of biopsy-verified cancer of the pharynx, larynx or oral cavity~* is referred to curative intended radiotherapy~* understands the given information and has given informed consent and~* age above 18 years.~Exclusion Criteria:~Pregnancy, lactation/breast feeding, age above 85 years, obesity (bodyweight above 140 kg), small cancers of the larynx (1A,1B), allergy to 68Ga-NOTA-AE105, metastasis on FDG-PET/CT, other previously known cancers, claustrophobia.~-

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- 68Ga-NOTA-AE105 (Type: EXPERIMENTAL): All participants have an uPAR-PET/CT scan performed before initiation of the routine radiotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).